CorVel/$CRVL
1D1W1M3M6MYTD1Y5YMAX
Capital at risk
About CorVel
CorVel Corp applies technology including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs. It partners with employers, third-party administrators, insurance companies, and government agencies in managing worker's compensation and health, auto, and liability services. The company's solutions combine integrated technologies with a human touch providing services that include claims management, bill review, preferred provider networks, utilization management, case management, pharmacy services, directed care, and medicare services.
- Ticker
- $CRVL
- Sector
- Health
- Primary listing
- NASDAQ
- Employees
- 5,239
- Headquarters
- Fort Worth, United States
- Website
- www.corvel.com
CorVel Metrics
BasicAdvanced
$4.2B
36.55
$2.25
0.95
-
Price and volume
Market cap
$4.2B
Beta
0.95
52-week high
$85.15
52-week low
$44.83
Average daily volume
175K
Financial strength
Current ratio
1.941
Quick ratio
1.411
Long term debt to equity
0.051
Total debt to equity
0.051
Profitability
EBITDA (TTM)
183.307
Gross margin (TTM)
24.79%
Net profit margin (TTM)
11.72%
Operating margin (TTM)
15.37%
Effective tax rate (TTM)
23.72%
Revenue per employee (TTM)
$190,000
Management effectiveness
Return on assets (TTM)
14.68%
Return on equity (TTM)
30.70%
Valuation
Price to earnings (TTM)
36.553
Price to revenue (TTM)
4.275
Price to book
10.22
Price to tangible book (TTM)
11.4
Price to free cash flow (TTM)
36.946
Free cash flow yield (TTM)
2.71%
Free cash flow per share (TTM)
2.225
Growth
Revenue change (TTM)
7.09%
Earnings per share change (TTM)
16.55%
3-year revenue growth (CAGR)
10.33%
10-year revenue growth (CAGR)
6.89%
3-year earnings per share growth (CAGR)
19.35%
10-year earnings per share growth (CAGR)
16.46%
Bulls say / Bears say
Claims volume rose 8% year on year, while new customer sales were up more than 60% in the quarter and 40% over the past 12 months. That points to stronger demand and a growing sales pipeline. (CorVel earnings call transcript)
June-quarter revenue rose 11% and gross profit grew 19%, lifting gross margin to 26%; diluted EPS increased 21% to $0.63. The faster rise in gross profit suggests CorVel is converting growth into improved profitability. (SEC)
CorVel has made its managed-care services accessible within Guidewire ClaimCenter, with automated data exchange and live status updates. This could make its services easier for insurers to adopt by fitting them into existing claims workflows. (GlobeNewswire)
Management said a settlement of legacy accounts receivable boosted June-quarter earnings by about $0.07 per share. That is a meaningful one-off contribution to reported diluted EPS of $0.63, so the headline growth overstates the underlying run rate. (CorVel earnings call transcript)
CorVel warns that competition, medical inflation and wage costs, regulatory changes, and a possible decline in workers’ compensation claims could weigh on growth and margins. The company also says customers may bring services in-house or shift work to larger rivals. (SEC)
CorVel’s shares trade at a premium to the wider US healthcare sector, with a P/E of 33.1 times compared with 24.1 times for the sector. That leaves less room for disappointment if growth slows or new products fail to gain traction. (Simply Wall St)
Data summarised monthly by Lightyear AI. Last updated on 13 Oct 2026.
CorVel Financial Performance
Revenues and expenses
Upcoming events
No upcoming events
CorVel News
AllArticlesVideos
Funds containing CorVel
AllUSDEURGBP
Fund name | Fund size | $CRVL weighting |
|---|---|---|
iShares Healthcare Innovation£DRDR | $1.3B | 0.23% |
iShares Healthcare Innovation€2B78 | $1.2B | 0.23% |
iShares Healthcare Innovation$HEAL | $1.3B | 0.23% |
iShares S&P SmallCap 600$IDP6 | $3.2B | 0.14% |
iShares S&P Small Cap 600£ISP6 | $3.2B | 0.14% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.